Table 2_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx
<p>mRNA platforms offer a promising strategy to overcome limitations in helminth vaccinology. We used the helminth Fasciola hepatica, which is a major veterinary and zoonotic pathogen for which no licensed vaccine exists, as a test case. We engineered a codon-optimized mRNA encoding the F. hep...
Tallennettuna:
| Päätekijä: | Javier Sánchez-Montejo (22681769) (author) |
|---|---|
| Muut tekijät: | Cristina Teodosio (143750) (author), Tania Strilets (14883102) (author), Julio López-Abán (134057) (author), Raúl Manzano-Román (3335778) (author), Julio Pozo (18986489) (author), Silvia Martin (22681772) (author), Lidia Silos (20912975) (author), Ignacio Trujillo (16072388) (author), Mariano A. García-Blanco (22681775) (author), Belén Vicente (615664) (author), Antonio Muro (134062) (author) |
| Julkaistu: |
2025
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia
-
Table 3_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx
Tekijä: Javier Sánchez-Montejo (22681769)
Julkaistu: (2025) -
Table 1_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx
Tekijä: Javier Sánchez-Montejo (22681769)
Julkaistu: (2025) -
Data Sheet 1_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx
Tekijä: Javier Sánchez-Montejo (22681769)
Julkaistu: (2025) -
Genetic variation and mRNA expression of the <i>ELOVL6</i> and <i>CRTC2</i> genes in Kalmyk cattle
Tekijä: Nurlybay Kazhgaliyev (9904228)
Julkaistu: (2025) -
Image 3_A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project.pdf
Tekijä: Stefano Ugel (7402733)
Julkaistu: (2025)